"Swimming Toward a Cure" documentary showing 1 p.m. Feb. 10 in Ann Arbor
The documentary film "Swimmng Toward a Cure," about last summer's English Channel relay swim by six Michigan women raising money for ALS research, will debut Sunday, Feb. 10 at 1 p.m. in the Blau Auditorium of the U-M Ross School of Business.
The swimmers broke the existing relay record and have collected nearly $100,000 toward their $120,000 goal. They are affiliated with Ann Arbor Active Against ALS (A2A3), a grass-roots non-profit organization that funds research into new treatments for amyotrophic lateral sclerosis (ALS). A reception and Q&A with the swimmers will follow the film showing. Suggested donation is $10 per individual or $25 per family.
For complete details, please click here.
Taubman-sponsored research offers breast tumor insights
Taubman Emerging Scholar Dr. Scott Tomlins has authored a new study about phyllodes tumors.
New U-M President visits Taubman Institute
The Institute hosted a fellow clinician-scientist when the University of Michigan’s new president paid a visit to the A. Alfred Taubman Biomedical Science Research Building.
Familial ALS affects generations
Detroit News column featuring Dr. Eva Feldman depicts the toll of the disease on one Metro Detroit family
news & events
In the News
PBS series features institute director on Jan. 18
"The Embrace of Aging," a documentary series airing Sundays at 2:30 p.m. on Detroit Public Televsion, features Taubman Institute Director Eva Feldman, M.D., Ph.D. and her landmark ALS stem cell trial in the Jan. 18 episode.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.